Table 3 Correlation between beclin 1 mRNA expression in breast cancer and clinicopathologic parameters
From: Genetic and epigenetic silencing of the beclin 1gene in sporadic breast tumors
| Â | Case number | Average of log T/N | Standard deviation of log T/N | P-value |
|---|---|---|---|---|
Age (y) | Â | Â | Â | Â |
   50 | 11 | -0.13 | 0.06 | 0.160 |
   ≥50 | 9 | -0.30 | 0.07 |  |
Lymphatic invasion | Â | Â | Â | Â |
   Positive | 8 | -0.23 | 0.06 | 0.356 |
   Negative | 11 | -0.13 | 0.05 |  |
ER | Â | Â | Â | Â |
   Positive | 7 | -0.31 | 0.08 | 0.199 |
   Negative | 13 | -0.15 | 0.06 |  |
PR | Â | Â | Â | Â |
   Positive | 10 | -0.20 | 0.06 | 0.905 |
   Negative | 10 | -0.21 | 0.09 |  |
HER2 | Â | Â | Â | Â |
   Positive | 19 | -0.21 | 0.07 | - |
   Negative | 1 | -0.07 | - |  |